BOT 1.45% 34.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-625

  1. 295 Posts.
    lightbulb Created with Sketch. 325
    correct, same with the table (thanks aburbe) from the ACZONE trial for secondary: trial 006 inflammatory lesion ACZONE = 56% Vehicle = 49%
    trial 007 ACZONE = 54% Vehicle = 48%
    Non-inflammatory ACZONE 45% Vehicle 39% & 46% and 41% respectively!!
    https://hotcopper.com.au/data/attachments/1790/1790997-276ebf6ca9f4e0e022b395886976291d.jpg
    https://hotcopper.com.au/threads/ann-botanix-announces-btx-1503-data-and-progression-to-phase-3.5026520/page-306?post_id=41022719
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
-0.005(1.45%)
Mkt cap ! $615.4M
Open High Low Value Volume
34.0¢ 34.0¢ 32.8¢ $1.949M 5.840M

Buyers (Bids)

No. Vol. Price($)
1 2985 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 420471 4
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.